ATE276752T1 - Verwendung von niedermolekularen heparinen zur vorbeugung und behandlung von einem trauma des zentralnervensystems - Google Patents

Verwendung von niedermolekularen heparinen zur vorbeugung und behandlung von einem trauma des zentralnervensystems

Info

Publication number
ATE276752T1
ATE276752T1 AT98925773T AT98925773T ATE276752T1 AT E276752 T1 ATE276752 T1 AT E276752T1 AT 98925773 T AT98925773 T AT 98925773T AT 98925773 T AT98925773 T AT 98925773T AT E276752 T1 ATE276752 T1 AT E276752T1
Authority
AT
Austria
Prior art keywords
prevention
treatment
low molecular
nervous system
central nervous
Prior art date
Application number
AT98925773T
Other languages
English (en)
Inventor
Jean-Marie Stutzmann
Andre Uzan
Florence Wahl
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE276752T1 publication Critical patent/ATE276752T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT98925773T 1997-05-28 1998-05-25 Verwendung von niedermolekularen heparinen zur vorbeugung und behandlung von einem trauma des zentralnervensystems ATE276752T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706550A FR2763848B1 (fr) 1997-05-28 1997-05-28 Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central
PCT/FR1998/001034 WO1998053833A1 (fr) 1997-05-28 1998-05-25 Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central

Publications (1)

Publication Number Publication Date
ATE276752T1 true ATE276752T1 (de) 2004-10-15

Family

ID=9507335

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98925773T ATE276752T1 (de) 1997-05-28 1998-05-25 Verwendung von niedermolekularen heparinen zur vorbeugung und behandlung von einem trauma des zentralnervensystems

Country Status (24)

Country Link
US (1) US6380173B1 (de)
EP (2) EP0984786B1 (de)
JP (1) JP2002500660A (de)
KR (1) KR100531721B1 (de)
CN (1) CN1212845C (de)
AR (1) AR012876A1 (de)
AT (1) ATE276752T1 (de)
AU (1) AU752322B2 (de)
BR (1) BR9809504A (de)
CA (1) CA2290675A1 (de)
DE (1) DE69826460T2 (de)
ES (1) ES2227841T3 (de)
FR (1) FR2763848B1 (de)
IL (2) IL132671A0 (de)
MA (1) MA24553A1 (de)
NO (1) NO317517B1 (de)
NZ (1) NZ501365A (de)
PE (1) PE74699A1 (de)
PT (1) PT984786E (de)
RU (1) RU2215531C2 (de)
TN (1) TNSN98071A1 (de)
TW (1) TW533075B (de)
WO (1) WO1998053833A1 (de)
ZA (1) ZA984432B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010041686A1 (en) * 2000-01-06 2001-11-15 Veronique Mary Novel therapeutic application of enoxaparin
US9308220B2 (en) 2001-12-11 2016-04-12 Cosmo Technologies Limited Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
ITMI20012599A1 (it) * 2001-12-11 2003-06-11 Cosmo Spa Composizioni farmaceutiche per la somministrazione orale di eparina osuoi derivati, utili per la terapia di malattie infiammatorie dell'int
US7511026B2 (en) 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
ITMI20031023A1 (it) * 2003-05-21 2004-11-22 Umberto Cornelli Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1195322A (en) * 1982-07-19 1985-10-15 Eduardo Amaya Process for manufacturing low molecular weight heparins by depolymerization of normal heparin
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
RU2024262C1 (ru) * 1991-05-28 1994-12-15 Михайлова Нина Геннадьевна Способ лечения повреждений центральной нервной системы
IT1264530B (it) * 1992-07-31 1996-10-02 Crinos Industria Farmaco Impiego dei polisaccaridi nelle neuropatie atrofico degenerative

Also Published As

Publication number Publication date
RU2215531C2 (ru) 2003-11-10
US6380173B1 (en) 2002-04-30
PT984786E (pt) 2005-01-31
DE69826460D1 (de) 2004-10-28
EP0984786B1 (de) 2004-09-22
CN1257428A (zh) 2000-06-21
ZA984432B (en) 1998-12-02
FR2763848B1 (fr) 2000-01-28
JP2002500660A (ja) 2002-01-08
NO995538L (no) 1999-11-12
TNSN98071A1 (fr) 2005-03-15
TW533075B (en) 2003-05-21
AU7775998A (en) 1998-12-30
MA24553A1 (fr) 1998-12-31
CN1212845C (zh) 2005-08-03
WO1998053833A1 (fr) 1998-12-03
EP1421943A1 (de) 2004-05-26
KR20010012988A (ko) 2001-02-26
DE69826460T2 (de) 2005-10-13
IL132671A0 (en) 2001-03-19
PE74699A1 (es) 1999-10-21
CA2290675A1 (fr) 1998-12-03
EP0984786A1 (de) 2000-03-15
NO995538D0 (no) 1999-11-12
AU752322B2 (en) 2002-09-19
IL132671A (en) 2007-06-17
AR012876A1 (es) 2000-11-22
NO317517B1 (no) 2004-11-08
KR100531721B1 (ko) 2005-11-28
BR9809504A (pt) 2000-06-20
NZ501365A (en) 2002-12-20
ES2227841T3 (es) 2005-04-01
FR2763848A1 (fr) 1998-12-04

Similar Documents

Publication Publication Date Title
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69823459D1 (de) Herzbehandlungssystem zur Feststellung und Behandlung von Herzversagen
DE69729284D1 (de) Filmbildende zusammensetzungen von antihyperalgesischen opiaten und deren verwendung zur behandlung von hyperalgesie
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69737402D1 (de) Vorrichtung zur Behandlung von neurodegenerativen Störungen
DE69622074D1 (de) Cystin-Silikon-Copolymere und deren Verwendung zur Behandlung von keratinischen Materialien
DE69704877D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
ATE527022T1 (de) Verwendung von cyclooxygenase-2-inhibitoren zur behandlung und vorbeugung von tumoren, von tumor- abhängigen erkrankungen und kachexie
EP0709090A3 (de) Zusammensetzungen zur Behandlung von resistenten Tumoren
DE69527749D1 (de) Kugelförmige Aktivkohle zur Behandlung von Bauchentzündungen
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
EP1043983A4 (de) Tetracycline und/oder tetracyclinderivate zur behandlung und prophylaxe von cerebrovascularen krankheiten des nervensystems
ATE227278T1 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
DE69624243D1 (de) Verwendung von unverdaulichen oligosacchariden zur vorbeugung und behandlung von mittelohrentzündung bei menschen
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
ATE347372T1 (de) Vakzine zur behandlung von mycosen
DE69912670D1 (de) Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69823339D1 (de) Atropisomere 3-heteroaryl-4(3h)-chinazolinone zur behandlung von neurodegenerativen und cns-trauma zuständen
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
DE69519602D1 (de) Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69814993D1 (de) Quasi-azeotrope Mischungen auf Basis von 1,1,1,3,3,-Pentafluorobutan, Methylene Chloride und Methanol zur Behandlung von festen Oberflächen
DE59705697D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung der seborrhoischen dermatitis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0984786

Country of ref document: EP

REN Ceased due to non-payment of the annual fee